1. Home
  2. ACT vs GRFS Comparison

ACT vs GRFS Comparison

Compare ACT & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enact Holdings Inc.

ACT

Enact Holdings Inc.

HOLD

Current Price

$38.96

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.98

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACT
GRFS
Founded
1981
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.2B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
ACT
GRFS
Price
$38.96
$8.98
Analyst Decision
Hold
Hold
Analyst Count
3
2
Target Price
$41.00
$10.15
AVG Volume (30 Days)
267.9K
493.4K
Earning Date
02-03-2026
07-28-2022
Dividend Yield
2.19%
1.65%
EPS Growth
1.64
N/A
EPS
4.36
0.64
Revenue
$1,224,897,000.00
$8,821,017,248.00
Revenue This Year
$4.60
$5.36
Revenue Next Year
$3.50
$5.15
P/E Ratio
$8.82
$16.93
Revenue Growth
2.40
7.31
52 Week Low
$31.28
$6.19
52 Week High
$41.35
$11.14

Technical Indicators

Market Signals
Indicator
ACT
GRFS
Relative Strength Index (RSI) 46.97 47.73
Support Level $37.49 $8.63
Resistance Level $39.31 $9.40
Average True Range (ATR) 0.91 0.23
MACD -0.22 -0.06
Stochastic Oscillator 36.40 34.57

Price Performance

Historical Comparison
ACT
GRFS

About ACT Enact Holdings Inc.

Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: